Halozyme Therapeutics Inc (HALO)
51.54
+0.68
(+1.34%)
USD |
NASDAQ |
Jun 21, 16:00
51.54
0.00 (0.00%)
After-Hours: 16:24
Halozyme Therapeutics Gross Profit (TTM): 677.47M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 677.47M |
December 31, 2023 | 636.89M |
September 30, 2023 | 598.53M |
June 30, 2023 | 598.97M |
March 31, 2023 | 546.43M |
December 31, 2022 | 520.81M |
September 30, 2022 | 461.85M |
June 30, 2022 | 397.44M |
March 31, 2022 | 392.45M |
December 31, 2021 | 361.90M |
September 30, 2021 | 376.91M |
June 30, 2021 | 339.42M |
March 31, 2021 | 275.46M |
December 31, 2020 | 224.23M |
September 30, 2020 | 165.77M |
June 30, 2020 | 129.92M |
March 31, 2020 | 117.71M |
December 31, 2019 | 150.45M |
September 30, 2019 | 168.08M |
June 30, 2019 | 169.11M |
March 31, 2019 | 166.21M |
December 31, 2018 | 141.73M |
September 30, 2018 | 269.19M |
June 30, 2018 | 299.66M |
March 31, 2018 | 291.26M |
Date | Value |
---|---|
December 31, 2017 | 285.46M |
September 30, 2017 | 134.39M |
June 30, 2017 | 101.71M |
March 31, 2017 | 100.77M |
December 31, 2016 | 113.48M |
September 30, 2016 | 126.28M |
June 30, 2016 | 118.16M |
March 31, 2016 | 128.38M |
December 31, 2015 | 105.81M |
September 30, 2015 | 86.24M |
June 30, 2015 | 81.11M |
March 31, 2015 | 58.33M |
December 31, 2014 | 52.60M |
September 30, 2014 | 37.33M |
June 30, 2014 | 43.20M |
March 31, 2014 | 43.90M |
December 31, 2013 | 48.55M |
September 30, 2013 | 60.73M |
June 30, 2013 | 50.51M |
March 31, 2013 | 44.96M |
December 31, 2012 | 41.23M |
September 30, 2012 | 22.45M |
June 30, 2012 | 40.27M |
March 31, 2012 | 55.67M |
December 31, 2011 | 55.83M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
117.71M
Minimum
Mar 2020
677.47M
Maximum
Mar 2024
365.49M
Average
369.40M
Median
Gross Profit (TTM) Benchmarks
Novavax Inc | 424.85M |
Denali Therapeutics Inc | -- |
Allogene Therapeutics Inc | -- |
AIM ImmunoTech Inc | 0.143M |
Protalix BioTherapeutics Inc | 37.16M |